camptothecin has been researched along with tetraphenylporphine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Das, BB; Das, SK; Ghosh, A; Halder, N; Paul Chowdhuri, S; Rath, H; Rehman, I; Sahoo, KC; Sengupta, S | 1 |
| Baykara, T; Sezgin, Z; Yüksel, N | 1 |
| Liao, Y; Ma, D; Mao, W | 1 |
3 other study(ies) available for camptothecin and tetraphenylporphine
| Article | Year |
|---|---|
Neutral Porphyrin Derivative Exerts Anticancer Activity by Targeting Cellular Topoisomerase I (Top1) and Promotes Apoptotic Cell Death without Stabilizing Top1-DNA Cleavage Complexes.
Topics: Antineoplastic Agents; Apoptosis; Biocatalysis; DNA Breaks; DNA Cleavage; DNA Topoisomerases, Type I; Humans; MCF-7 Cells; Porphyrins; Reactive Oxygen Species; Topoisomerase I Inhibitors | 2018 |
Preparation and characterization of polymeric micelles for solubilization of poorly soluble anticancer drugs.
Topics: Antineoplastic Agents; Camptothecin; Chemistry, Pharmaceutical; Drug Carriers; Drug Stability; Hydrophobic and Hydrophilic Interactions; Micelles; Particle Size; Phosphatidylethanolamines; Poloxamer; Polyethylene Glycols; Polymers; Porphyrins; Solubility; Structure-Activity Relationship; Time Factors | 2006 |
A supramolecular assembly mediated by host-guest interactions for improved chemo-photodynamic combination therapy.
Topics: A549 Cells; Antineoplastic Agents; Camptothecin; Cell Proliferation; Cell Survival; Drug Screening Assays, Antitumor; HeLa Cells; Humans; Macrocyclic Compounds; Macromolecular Substances; MCF-7 Cells; Molecular Structure; Nanomedicine; Particle Size; Photochemotherapy; Polyethylene Glycols; Porphyrins; Surface Properties | 2020 |